Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B

Oncogene volume 27, pages 6581–6589 (2008)Cite this article

Abstract

SEMA3B, a member of class 3 semaphorins, is a tumor suppressor. Competition with vascular endothelial growth factor (VEGF)165 explains a portion of the activity, whereas the VEGF-independent mechanism was not elucidated. We employed a microarray and screened for the genes whose expression was increased by SEMA3B in NCI-H1299 cells. Insulin-like growth factor-binding protein-6 (IGFBP-6), a tumor suppressor, showed greatest difference in the expression level. Introduction of IGFBP-6 cDNA reduced colony formation both on the dish surface and in soft agar. Insulin-like growth factor II, which antagonizes IGFBP-6, partly abrogated the effect. Inhibition of IGFBP-6 by small interfering RNA diminished the sub-G0/G1 population that was induced by SEMA3B and abrogated the growth suppressive effect of SEMA3B. We concluded that IGFBP-6 is the effector of tumor suppressor activity of SEMA3B in NCI-H1299 cells. It has been reported that β-catenin suppresses the expression of IGFBP-6. Introduction of β-catenin into the cells partly abrogated the growth suppressive effect of SEMA3B. Our result indicates that semaphorin signaling and β-catenin signaling converge on IGFBP-6 and antithetically affect their functions.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Bach LA . (1999). Insulin-like growth factor binding protein-6: the ‘forgotten’ binding protein? Horm Metab Res 31: 226–234.

    Article  CAS  Google Scholar 

  • Bach LA, Hsieh S, Brown AL, Rechler MM . (1994). Recombinant human insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced differentiation of L6A1 myoblasts. Endocrinology 135: 2168–2176.

    Article  CAS  Google Scholar 

  • Bach LA, Salemi R, Leeding KS . (1995). Roles of insulin-like growth factor (IGF) receptors and IGF-binding proteins in IGF-II-induced proliferation and differentiation of L6A1 rat myoblasts. Endocrinology 136: 5061–5069.

    Article  CAS  Google Scholar 

  • Barz T, Hoffmann A, Panhuysen M, Spengler D . (2006). Peroxisome proliferator-activated receptor gamma is a Zac target gene mediating Zac antiproliferation. Cancer Res 66: 11975–11982.

    Article  CAS  Google Scholar 

  • Behar O, Golden JA, Mashimo H, Schoen FJ, Fishman MC . (1996). Semaphorin III is needed for normal patterning and growth of nerves, bones and heart. Nature 383: 525–528.

    Article  CAS  Google Scholar 

  • Castro-Rivera E, Ran S, Thorpe P, Minna JD . (2004). Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl Acad Sci USA 101: 11432–11437.

    Article  CAS  Google Scholar 

  • Chow LS, Lam CW, Chan SY, Tsao SW, To KF, Tong SF et al. (2006). Identification of RASSF1A modulated genes in nasopharyngeal carcinoma. Oncogene 25: 310–316.

    Article  CAS  Google Scholar 

  • Christensen CR, Klingelhofer J, Tarabykina S, Hulgaard EF, Kramerov D, Lukanidin E . (1998). Transcription of a novel mouse semaphorin gene, M-semaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res 58: 1238–1244.

    CAS  Google Scholar 

  • Clevers H . (2006). Wnt/beta-catenin signaling in development and disease. Cell 127: 469–480.

    Article  CAS  Google Scholar 

  • Denys H, Jadidizadeh A, Amini Nik S, Van Dam K, Aerts S, Alman BA et al. (2004). Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors. Oncogene 23: 654–664.

    Article  CAS  Google Scholar 

  • Feng X, Bonni S, Riabowol K . (2006). HSP70 induction by ING proteins sensitizes cells to tumor necrosis factor alpha receptor-mediated apoptosis. Mol Cell Biol 26: 9244–9255.

    Article  CAS  Google Scholar 

  • Firth SM, Baxter RC . (2002). Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23: 824–854.

    Article  CAS  Google Scholar 

  • Gallicchio MA, Kneen M, Hall C, Scott AM, Bach LA . (2001). Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer 94: 645–651.

    Article  CAS  Google Scholar 

  • Grellier P, De Galle B, Babajko S . (1998). Expression of insulin-like growth factor-binding protein 6 complementary DNA alters neuroblastoma cell growth. Cancer Res 58: 1670–1676.

    CAS  Google Scholar 

  • Gu C, Yoshida Y, Livet J, Reimert DV, Mann F, Merte J et al. (2005). Semaphorin 3E and plexin-D1 control vascular pattern independently of neuropilins. Science 307: 265–268.

    Article  CAS  Google Scholar 

  • Guttmann-Raviv N, Kessler O, Shraga-Heled N, Lange T, Herzog Y, Neufeld G . (2006). The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett 231: 1–11.

    Article  CAS  Google Scholar 

  • Hall KT, Boumsell L, Schultze JL, Boussiotis VA, Dorfman DM, Cardoso AA et al. (1996). Human CD100, a novel leukocyte semaphorin that promotes B-cell aggregation and differentiation. Proc Natl Acad Sci USA 93: 11780–11785.

    Article  CAS  Google Scholar 

  • He Z, Tessier-Lavigne M . (1997). Neuropilin is a receptor for the axonal chemorepellent Semaphorin III. Cell 90: 739–751.

    Article  CAS  Google Scholar 

  • Kannan K, Kaminski N, Rechavi G, Jakob-Hirsch J, Amariglio N, Givol D . (2001). DNA microarray analysis of genes involved in p53 mediated apoptosis: activation of Apaf-1. Oncogene 20: 3449–3455.

    Article  CAS  Google Scholar 

  • Kato M, Ishizaki A, Hellman U, Wernstedt C, Kyogoku M, Miyazono K et al. (1995). A human keratinocyte cell line produces two autocrine growth inhibitors, transforming growth factor-beta and insulin-like growth factor binding protein-6, in a calcium- and cell density-dependent manner. J Biol Chem 270: 12373–12379.

    Article  CAS  Google Scholar 

  • Koike H, Ito K, Takezawa Y, Oyama T, Yamanaka H, Suzuki K . (2005). Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer. Br J Cancer 92: 1538–1544.

    Article  CAS  Google Scholar 

  • Kolodkin AL, Matthes DJ, Goodman CS . (1993). The semaphorin genes encode a family of transmembrane and secreted growth cone guidance molecules. Cell 75: 1389–1399.

    Article  CAS  Google Scholar 

  • Leng SL, Leeding KS, Whitehead RH, Bach LA . (2001). Insulin-like growth factor (IGF)-binding protein-6 inhibits IGF-II-induced but not basal proliferation and adhesion of LIM 1215 colon cancer cells. Mol Cell Endocrinol 174: 121–127.

    Article  CAS  Google Scholar 

  • Mac Gabhann F, Popel AS . (2006). Targeting neuropilin-1 to inhibit VEGF signaling in cancer: comparison of therapeutic approaches. PLoS Comput Biol 2: e180.

    Article  Google Scholar 

  • Martin JL, Willetts KE, Baxter RC . (1990). Purification and properties of a novel insulin-like growth factor-II binding protein from transformed human fibroblasts. J Biol Chem 265: 4124–4130.

    CAS  Google Scholar 

  • Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M . (1999). Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 146: 233–242.

    CAS  Google Scholar 

  • Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D et al. (2005). Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion. Neoplasia 7: 180–189.

    Article  CAS  Google Scholar 

  • Nelson WJ, Nusse R . (2004). Convergence of Wnt, beta-catenin, and cadherin pathways. Science 303: 1483–1487.

    Article  CAS  Google Scholar 

  • Ochi K, Mori T, Toyama Y, Nakamura Y, Arakawa H . (2002). Identification of semaphorin3B as a direct target of p53. Neoplasia 4: 82–87.

    Article  CAS  Google Scholar 

  • Pasterkamp RJ, De Winter F, Holtmaat AJ, Verhaagen J . (1998). Evidence for a role of the chemorepellent semaphorin III and its receptor neuropilin-1 in the regeneration of primary olfactory axons. J Neurosci 18: 9962–9976.

    Article  CAS  Google Scholar 

  • Scholl FA, Betts DR, Niggli FK, Schafer BW . (2000). Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression. Br J Cancer 82: 1239–1245.

    Article  CAS  Google Scholar 

  • Sekido Y, Bader S, Latif F, Chen JY, Duh FM, Wei MH et al. (1996). Human semaphorins A(V) and IV reside in the 3p21.3 small cell lung cancer deletion region and demonstrate distinct expression patterns. Proc Natl Acad Sci USA 93: 4120–4125.

    Article  CAS  Google Scholar 

  • Soker S, Fidder H, Neufeld G, Klagsbrun M . (1996). Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. J Biol Chem 271: 5761–5767.

    Article  CAS  Google Scholar 

  • Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M . (1998). Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell 92: 735–745.

    Article  CAS  Google Scholar 

  • Sueoka N, Lee HY, Wiehle S, Cristiano RJ, Fang B, Ji L et al. (2000). Insulin-like growth factor binding protein-6 activates programmed cell death in non-small cell lung cancer cells. Oncogene 19: 4432–4436.

    Article  CAS  Google Scholar 

  • Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J et al. (2001). Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 98: 13954–13959.

    Article  CAS  Google Scholar 

  • Tran TS, Kolodkin AL, Bharadwaj R . (2007). Semaphorin regulation of cellular morphology. Annu Rev Cell Dev Biol 23: 263–292.

    Article  CAS  Google Scholar 

  • Usami N, Sekido Y, Maeda O, Yamamoto K, Minna JD, Hasegawa Y et al. (2003). Beta-catenin inhibits cell growth of a malignant mesothelioma cell line, NCI-H28, with a 3p21.3 homozygous deletion. Oncogene 22: 7923–7930.

    Article  Google Scholar 

  • Yao R, Wang Y, Lubet RA, You M . (2002). Differentially expressed genes associated with mouse lung tumor progression. Oncogene 21: 5814–5821.

    Article  CAS  Google Scholar 

  • Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B . (2001). PUMA induces the rapid apoptosis of colorectal cancer cells. Mol Cell 7: 673–682.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms Akemi Yokote for technical assistance. This study was supported in part by the following grants-in-aid: 1) for scientific research (nos. 18390242 and 16590738) from the Japan Society for the Promotion of Science and 2) for Comprehensive Research on Aging and Health from the Ministry of Health, Labor and Welfare, Japan.

Author information

Authors and Affiliations

  1. Department of Respiratory Medicine, Saitama Medical University, Saitama, Japan

    N Koyama, J Zhang,  Huqun, H Miyazawa, T Tanaka & K Hagiwara

  2. Clinical Research Center, Inner Mongolia Medical College, Hohhot, Inner Mongolia, China

    J Zhang & X Su

Authors
  1. N Koyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Huqun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Miyazawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. T Tanaka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. X Su
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. K Hagiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to N Koyama.

Additional information

Supplementary Information accompanies the paper on the Oncogene website (http://www.nature.com/onc)

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koyama, N., Zhang, J., Huqun et al. Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B. Oncogene 27, 6581–6589 (2008). https://doi.org/10.1038/onc.2008.263

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/onc.2008.263

Keywords

This article is cited by

Search

Advanced search

Quick links